Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Acta Neuropathologica

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00296548PMID 1767631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin

  2004cited by this paper
• Lower motor neuron disease in a patient with auto‐antibodies against Gal(β 1‐3)GalNAc in gangliosides GM1 and GD1b

  1990cited by this paper
• IgM deposits at nodes of ranvier in a patient with amyotrophic lateral sclerosis, anti‐GM1 antibodies, and multifocal motor conduction block

  1990cited by this paper
• Human Monoclonal IgM Anti-Gal(β1-3)GalNAc Autoantibodies Bind to the Surface of Bovine Spinal Motoneurons

  1990cited by this paper
• A syndrome of asymmetric limb weakness with motor conduction block

  1990cited by this paper
• Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies

  1990cited by this paper
• The spectrum of neurologic disease associated with anti‐GM1 antibodies

  1990cited by this paper
• Motor dominant neuropathy and IgM paraproteinemia: the IgM M-protein binds to specific gangliosides.

  1989cited by this paper
• Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy.

  1989cited by this paper
• Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease.

  1989cited by this paper
• Monoclonal IgMs with anti-Gal(beta 1-3) GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins.

  1989cited by this paper
• Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia

  1989cited by this paper
• Monoclonal IgM in two patients with motor neuron disease bind to the carbohydrate antigens Gal(beta 1-3)GalNAc and Gal(beta 1-3)GlcNAc.

  1988cited by this paper
• Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b

  1988cited by this paper
• Generation of Antibodies to Gangliosides GM1 and GD1b

  1988cited by this paper
• Monoclonal IgM in two patients with motor neuron disease bind to the carbohydrate antigens Gal(β1–3)GalNAc and Gal(β1–3)GlcNAc

  1988cited by this paper
• Generation of antibodies to gangliosides GM1 and GD1b. Genetic control of fine antigenic specificity.

  1988cited by this paper
• Identification and Characterization of Gangliosides Reacting with IgM Paraproteins in Three Patients with Neuropathy Associated with Biclonal Gammopathy

  1988cited by this paper
• A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside

  1988cited by this paper
• Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto‐N ‐tetraose associated with human motor neuron disease

  1988cited by this paper
• Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease

  1986cited by this paper
• Peanut Agglutinin Receptor Is a Marker of Myelin in Rat Brain. Developmental Changes in Its Distribution

  1986cited by this paper
• Specific modulation of sodium channels in mammalian nerve by monoclonal antibodies.

  1986cited by this paper
• Natural Autoantibodies Constitute a Substantial Part of Normal Circulating Immunoglobulins

  1986cited by this paper
• Antisera to different glycolipids induce myelin alterations in mouse spinal cord tissue cultures.

  1985cited by this paper
• Histochemical localization of galactose-containing glycoconjugate at peripheral nodes of Ranvier in the rat.

  1985cited by this paper
• Immunofluorescence study of patients with neuropathy and IgM M proteins

  1985cited by this paper
• Carbohydrate structures of glycoproteins and glycolipids as differentiation antigens, tumour-associated antigens and components of receptor systems

  1985cited by this paper
• Regenerative capacity of the goldfish visual system is affected by antibodies specific to gangliosides injected intraocularly.

  1984cited by this paper
• Antibodies to gangliosides inhibit goldfish optic nerve regeneration in vivo

  1984cited by this paper
• Ganglioside distribution at different levels of organization and its biological implications.

  1984cited by this paper
• Ganglioside localization on myelinated nerve fibres by cholera toxin binding

  1983cited by this paper
• Sprouting from chicken embryo dorsal root ganglia induced by nerve growth factor is specifically inhibited by affinity-purified antiganglioside antibodies.

  1982cited by this paper
• Conduction velocity and conduction block after experimental ischaemic nerve injury.

  1981cited by this paper
• Abnormal maturation of cerebral cortex and behavioral deficit in adult rats after neonatal administration of antibodies to ganglioside.

  1981cited by this paper
• Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides.

  1976cited by this paper
• Gangliosides of the peripheral nervous system of the rat.

  1975cited by this paper
• CHANGES IN THE SCIATIC NERVE OF THE RABBIT AND ITS TISSUE CONSTITUENTS DURING DEVELOPMENT 1

  1974cited by this paper
• Sphingolipids of human skeletal muscle

  1972cited by this paper
• Sphinolipids of human skeletal muscle.

  1972cited by this paper

• Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies

  2025cites this paper
• IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor Neuropathy

  2025cites this paper
• Multifocal Motor Neuropathy: A Narrative Review

  2025cites this paper
• Histological and Clinical Findings in Rabbits Sensitized with GM1 Ganglioside

  2020cites this paper
• Nerve ultrasound as follow‐up tool in treated multifocal motor neuropathy

  2017cites this paper
• Experimental Guillain-Barre syndrome induced by immunization with gangliosides: Keyhole limpet hemocyanin is required for disease triggering.

  2017cites this paper
• Neurologic autoimmunity: mechanisms revealed by animal models.

  2016cites this paper
• Human Anti-Glycosphingolipids Antibodies in Guillain-Barré Syndrome

  2014cites this paper
• Autoantibody Testing in Peripheral Neuropathy

  2014cites this paper
• Antibody testing in peripheral nerve disorders.

  2013cites this paper
• Harnessing in and ex vivo imaging to investigate motor nerve terminal injury and recovery in a mouse model of Guillain-Barré syndrome

  2012influential citation
• Guillain–Barré syndrome and anti-ganglioside antibodies: a clinician-scientist’s journey

  2012cites this paper
• Anti-glycolipid Antibodies in Guillain-Barré Syndrome and Related Neuropathies: Therapeutic Strategies for Disease Treatment

  2012cites this paper
• Pathological roles of ganglioside mimicry in Guillain-Barré syndrome and related neuropathies.

  2011cites this paper
• Campylobacter jejuni Serotype HS:10 Capsular Polysaccharide and the Conjugate Vaccine thereof

  2011cites this paper
• Reversible conduction failure in pharyngeal‐cervical‐brachial variant of guillain‐barré syndrome

  2010cites this paper
• Demyelinating symmetric motor polyneuropathy with high titers of anti‐GM1 antibodies

  2010cites this paper
• Anti-GD1a antibody targeted disruption of the node of Ranvier in a mouse model of acute motor axonal neuropathy

  2009cites this paper
• Neuroimmunology of Paraproteinemic Neuropathies

  2009cites this paper
• Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block.

  2008cites this paper
• B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.

  2008cites this paper
• Les anticorps antigangliosides sont-ils augmentés par la chirurgie lombaire ?

  2008cites this paper
• Anti-GM1 antibodies as a model of the immune response to self-glycans.

  2008cites this paper
• Validation of a rabbit model of neuropathy induced by immunization with gangliosides.

  2008cites this paper
• Ca channel currents inhibited by serum from select patients with Guillain-Barré syndrome.

  2007cites this paper
• Lewis rats immunized with GM1 ganglioside do not develop peripheral neuropathy.

  2007cites this paper
• High affinity of anti‐GM1 antibodies is associated with disease onset in experimental neuropathy

  2006cites this paper
• IgM anti-GM1 antibody titers in patients with monomelic amyotrophy.

  2006cites this paper
• Models of Systemic Lupus Erythematosus: Development of Autoimmunity Following Peptide Immunizations of Noninbred Pedigreed Rabbits1

  2006cites this paper
• Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti‐GM1 antibody and neuropathy

  2006cites this paper
• Ca2+ Channel Currents Inhibited by Serum from Select Patients with Guillain-Barré Syndrome

  2006cites this paper
• Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome.

  2006cites this paper
• Anti‐ganglioside antibodies and elevated CSF IgG levels in Guillain‐Barré syndrome

  2006cites this paper
• Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies.

  2006cites this paper
• Pedigreed Rabbits Peptide Immunizations of Noninbred Development of Autoimmunity Following Models of Systemic Lupus Erythematosus:

  2005cites this paper
• Chapter 97 – Polyneuropathies and Antibodies to Nerve Components

  2005cites this paper
• Peptide Immunizations of Noninbred Development of Autoimmunity Following Models of Systemic Lupus Erythematosus:

  2005cites this paper
• ELISA-Type Titertray Assay of 1 gMAnti-GM 1 Autoantibodies

  2004cites this paper
• Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni.

  2004cites this paper
• Various immunization protocols for an acute motor axonal neuropathy rabbit model compared.

  2004cites this paper
• Peripheral nervous system and central nervous system pathology in rapidly progressive lower motor neuron syndrome with immunoglobulin M anti‐GM1 ganglioside antibody

  2004influential citation
• ANALYSIS OF THE ORGANOPHOSPHATE-INDUCED ELECTROMYOGRAPHIC RESPONSE

  2004cites this paper
• Autoimmune responses in peripheral nerve

  2004cites this paper
• Functional Organization of the Nodes of Ranvier

  2004cites this paper
• Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barré syndrome.

  2003cites this paper
• The spectrum of lower motor neuron syndromes

  2003cites this paper
• Induction of conduction block by Campylobacter jejuni lipopolysaccharides and focal neural insult.

  2003cites this paper
• Association of anti-GM1 antibodies but not of anti-cytomegalovirus, Campylobacter jejuni and Helicobacter pylori IgG, with a poor outcome in Guillain-Barré syndrome.

  2003cites this paper
• Rabbit model of Guillain‐Barré syndrome

  2002cites this paper
• Peripheral neuropathies and anti-glycolipid antibodies.

  2002cites this paper
• Reply

  2002cites this paper
• The Origin of Anti-GM1 Antibodies in Neuropathies: The “Binding Site Drift” Hypothesis

  2002cites this paper
• High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies.

  2002cites this paper
• Creatine supplementation results in elevated phosphocreatine/adenosine triphosphate (ATP) ratios in the calf muscle of athletes but not in patients with myopathies

  2002cites this paper
• Multifocal motor neuropathy.

  2002cites this paper
• Reply

  2002cites this paper
• Animal model of axonal Guillain‐Barré syndrome induced by sensitization with GM1 ganglioside

  2001cites this paper
• Guillain-Barré Syndrome- and Miller Fisher Syndrome-Associated Campylobacter jejuni Lipopolysaccharides Induce Anti-GM1 and Anti-GQ1b Antibodies in Rabbits

  2001cites this paper
• Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells.

  2001cites this paper
• Axonal Guillain–Barré syndrome: a critical review

  2001cites this paper
• Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.

  2000cites this paper
• Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.

  2000cites this paper
• Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome.

  2000cites this paper
• Auto-antibody tests in peripheral neuropathies: pros and cons

  2000cites this paper
• Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome

  2000cites this paper
• Anti-GM1 ganglioside antibodies: their role in the diagnosis and pathogenesis of immune-mediated motor neuropathies.

  2000cites this paper
• Therapeutic apheresis in neurological disorders

  2000cites this paper
• Results of testing for anti-GM1 antibodies.

  2000cites this paper
• The distribution of ganglioside-like moieties in peripheral nerves.

  1999cites this paper
• Monospecific anti‐GD1b IgG is required to induce rabbit ataxic neuropathy

  1999cites this paper
• Pathogenesis of Guillain-Barré syndrome.

  1999cites this paper
• Autoantibodies associated with peripheral neuropathy

  1999cites this paper
• Autoantibodies to Brain Components and Antibodies to Acinetobacter calcoaceticus Are Present in Bovine Spongiform Encephalopathy

  1999cites this paper
• Serotyping of Campylobacter jejuni based on heat stable antigens: relevance, molecular basis and implications in pathogenesis

  1999cites this paper
• Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.

  1999cites this paper
• Gangliosides and Glycosphingolipids of Peripheral Nervous System Myelins—a Minireview

  1998cites this paper
• Association of IgM type anti‐GM1 antibodies and muscle strength in chronic acquired demylelinating polyneuropathy

  1998cites this paper
• Guillain‐Barré Syndrome and Fisher's Syndrome Following Campylobacter jejuni Infection a

  1998cites this paper
• Antiganglioside GM1 Antibodies and Their Complement Activating Capacity in Central and Peripheral Nervous System Disorders and in Controls

  1998cites this paper
• Neuromuscular blockade by IgG antibodies from patients with Guillain‐Barré syndrome: A macro‐patch‐clamp study

  1998cites this paper
• Autoantibody Testing in the Evaluation of Peripheral Neuropathy

  1998cites this paper
• Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies

  1998cites this paper
• Anti-ganglioside antibody and neuropathy: review of our research.

  1998cites this paper
• Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.

  1998cites this paper
• IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course.

  1997cites this paper
• Experimental polyneuropathy produced in guinea‐pigs immunized against sulfatide

  1997cites this paper
• Insights into Campylobacter jejuni-induced Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis.

  1997cites this paper
• Multifocal motor neuropathy

  1997cites this paper
• [Multifocal motor neuropathy: an individualized disease of the peripheral nervous system].

  1997cites this paper
• Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome.

  1997cites this paper
• The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons.

  1997cites this paper
• Molecular specializations at nodes and paranodes in peripheral nerve

  1996cites this paper
• A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.

  1996cites this paper
• Experimental sensory neuropathy induced by sensitization with ganglioside GD1b

  1996cites this paper
• Antibodies to GM1 and Gal(β1–3)GalNAc at the nodes of Ranvier in human and experimental autoimmune neuropathy

  1996cites this paper
• Sensory pathophysiology in chronic acquired demyelinating neuropathy.

  1996cites this paper
• Anti-GM1 antibodies in polyneuropathies of unknown origin.

  1996cites this paper
• Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma

  1996cites this paper
• Anti-GM1 Ganglioside Antibodies Cloned from Autoimmune Neuropathy Patients Show Diverse Binding Patterns in the Rodent Nervous System

  1996cites this paper
• Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides

  1995cites this paper